Acute lung injury (ALI) and chronic lung disease are together the third leading cause of death in the United States, in part due to our incomplete understanding of the mechanisms that govern injury responses in the lung. Extracellular adenosine is generated following hypoxia, and serves to orchestrate tissue responses to injury by engaging adenosine receptors. This pathway is known as the hypoxic adenosine response. Our findings suggest that adenosine serves beneficial functions on features of ALI such as the maintenance of barrier function and the dampening of inflammation. In contrast, adenosine contributes to chronic lung injury by promoting fibrosis and the development of pulmonary hypertension secondary to fibrosis. Furthermore, our findings suggest that the AD0RA2B adenosine receptor regulates both the beneficial and detrimental aspects of adenosine in the lung. The goal of this Project is to better understand the mechanisms involved in adenosine-mediated protection during ALI and its role in disease progression in order to advance adenosine-based therapies for the treatment of lung disease. We have recently gained insight into two pathways that provide information on the differential roles of adenosine in lung disease. First, we show that the equilabrative nucleoside transporter 2 (ENT2) is down regulated during both acute and chronic lung injury. ENTs are critical regulators of extracellular adenosine and we hypothesize that their regulation is involved in adenosine's protective effects during ALI and it's harmful effects during chronic disease stages. Secondly, we show the emergence of AD0RA2B-dependent responses on alternately activated macrophages (AAMs) during chronic disease stages. These specialized macrophages contribute to chronic disease progression, and we hypothesize that AAMs contribute to the stage selective responses to adenosine that promote pulmonary fibrosis and pulmonary hypertension.
Four specific aims are designed to address these hypotheses and determine their significance towards human lung disease:
Aim 1. Examine the beneficial roles of adenosine in ALI, Aim 2. Examine alterations in the hypoxic adenosine response during disease progression;
Aim 3. Examine detrimental roles of adenosine in pulmonary hypertension secondary to fibrosis, and Aim 4. Examine the hypoxic adenosine response in patients with acute and chronic lung disease. Successful completion of this study will help promote the use of adenosine-based therapies for the treatment of lung disease.

Public Health Relevance

Acute and chronic lung diseases are the third leading cause of death in the United States. This is due in part to an incomplete understanding of injury responses in the lung. This Project is highly relevant to the betterment of human disease in that it will seek to identify new therapeutic targets for several different types of lung diseases, including acute lung injury and pulmonary hypertension secondary to fibrosis and sickle cell disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL114457-02
Application #
8665471
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
2
Fiscal Year
2014
Total Cost
$520,939
Indirect Cost
$178,216
Name
University of Texas Health Science Center Houston
Department
Type
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77225
Kork, Felix; Eltzschig, Holger K (2017) The Devil Is in the Detail: Remote Ischemic Preconditioning for Perioperative Kidney Protection. Anesthesiology 126:763-765
Song, Anren; Zhang, Yujin; Han, Leng et al. (2017) Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascent. Nat Commun 8:14108
Huang, Aji; Wu, Hongyu; Iriyama, Takayuki et al. (2017) Elevated Adenosine Induces Placental DNA Hypomethylation Independent of A2B Receptor Signaling in Preeclampsia. Hypertension 70:209-218
Hoegl, Sandra; Ehrentraut, Heidi; Brodsky, Kelley S et al. (2017) NK cells regulate CXCR2+ neutrophil recruitment during acute lung injury. J Leukoc Biol 101:471-480
Philip, Kemly; Mills, Tingting Weng; Davies, Jonathan et al. (2017) HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis. FASEB J 31:4745-4758
He, Baokun; Hoang, Thomas K; Wang, Ting et al. (2017) Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors. J Exp Med 214:107-123
Neudecker, Viola; Haneklaus, Moritz; Jensen, Owen et al. (2017) Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med 214:1737-1752
Varadarajan, Supraja G; Kong, Jennifer H; Phan, Keith D et al. (2017) Netrin1 Produced by Neural Progenitors, Not Floor Plate Cells, Is Required for Axon Guidance in the Spinal Cord. Neuron 94:790-799.e3
Wirsdörfer, Florian; de Leve, Simone; Cappuccini, Federica et al. (2016) Extracellular Adenosine Production by ecto-5'-Nucleotidase (CD73) Enhances Radiation-Induced Lung Fibrosis. Cancer Res 76:3045-56
Luo, Renna; Liu, Chen; Elliott, Serra E et al. (2016) Transglutaminase is a Critical Link Between Inflammation and Hypertension. J Am Heart Assoc 5:

Showing the most recent 10 out of 63 publications